** Citi highlights dairy co The A2 Milk Company ATM.NZ, A2M.AX for potential growth, following positive indicators from peer Health and Happiness (H&H) International's 1112.HK full-year results
** Says H&H's report suggests industry volume declines in the super premium segment have stabilised towards year-end, possibly reflecting the strong 2024 birth rate
** Citi emphasises significance of these results for ATM's premium Genesis line, which should benefit from potentially less price-competitive market environment
** Maintains "buy" rating; ASX-listed shares' PT of A$8.20
** ATM up 36.8% YTD
(Reporting by Kumar Tanishk and Nikita Maria Jino in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。